Ami Organics vs Clean Science and Technology: Share Price, Comparison and Key Differences
- August 10, 2026
- Posted by: Lakshit Sharma
- Category: News
Ami Organics MCap approx Rs 6,000 Cr, PE approx 40x, ROE approx 12%. Clean Science and Technology MCap Rs 8,205 Cr, PE 35.22x, ROE 14.50%, zero debt.
Ami Organics vs Clean Science and Technology is a comparison specialty chemical investors look up when evaluating two listed Indian fine chemical companies. Ami Organics is a Surat-based specialty chemical company making pharmaceutical intermediates for anti-viral, anti-depressant and anti-coagulant drug classes, along with specialty chemicals for global innovator pharma companies. Clean Science and Technology is a Pune-based company making performance chemicals – HALS, BHA, guaiacol, anisole and methoxy toluene – used in food, pharma, cosmetics and polymers using a proprietary green chemistry process.
This Ami Organics vs Clean Science and Technology article covers reach and market position, key products, latest declared results and stock valuation. The Ami Organics vs Clean Science and Technology data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Ami Organics vs Clean Science and Technology: Reach and Market Position
On the Ami Organics side of the Ami Organics vs Clean Science and Technology comparison, Ami Organics exports pharmaceutical intermediates to global pharma manufacturers in the US, Europe and Japan. Market capitalisation is approximately Rs 6,000 Cr.
Click Here – Get Free Investment Predictions
On the Clean Science and Technology side of the Ami Organics vs Clean Science and Technology comparison, Clean Science and Technology exports performance chemicals globally – particularly to European, Japanese and North American specialty chemical companies – with a focus on green chemistry processes. Market capitalisation is Rs 8,205 Cr.
Ami Organics vs Clean Science and Technology: Key Products and Business Mix
In the Ami Organics vs Clean Science and Technology product comparison, Ami Organics offers: Ami Organics earns from pharma intermediates for anti-depressants (sertraline HCl intermediates), anti-virals (favipiravir intermediates), anti-coagulants and contract manufacturing. PE is approximately 40x, ROE approximately 12 percent.
For Clean Science and Technology in this Ami Organics vs Clean Science and Technology breakdown: Clean Science earns from HALS (light stabilisers for polymers), guaiacol and related compounds for pharma and food, anisole, BHA and Dimethyl Carbonate. EPS is Rs 21.92. PE is 35.22x, ROE 14.50 percent, zero debt.
Ami Organics vs Clean Science and Technology: Latest Results
The Ami Organics vs Clean Science and Technology results for Ami Organics: Ami Organics has a market cap of approximately Rs 6,000 Cr. The company has been growing its pharma intermediate business and expanding its specialty chemical product range.
The Ami Organics vs Clean Science and Technology results for Clean Science and Technology: Clean Science and Technology has a market cap of Rs 8,205 Cr and PE of 35.22x. ROE is 14.50 percent with zero debt – an asset-light specialty chemicals model with good cash generation.
Compare Ami Organics and Clean Science and Technology Fundamentals on the Univest Screener
Ami Organics vs Clean Science and Technology: Stock and Valuation
The Ami Organics vs Clean Science and Technology stock comparison uses the latest available market data from Groww. Investors tracking Ami Organics vs Clean Science and Technology should verify current prices on NSE or BSE before trading.
Ami Organics vs Clean Science at current valuations: Ami Organics trades at approximately Rs 6,000 Cr market cap, PE approximately 40x, ROE approximately 12 percent. Clean Science trades at Rs 8,205 Cr market cap, PE 35.22x, ROE 14.50 percent, zero debt. Both are similarly sized specialty chemical companies. Clean Science is cheaper on PE and has higher ROE with zero debt.
Ami Organics vs Clean Science and Technology: Quick Comparison Table
The Ami Organics vs Clean Science and Technology comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Ami Organics | Clean Science and Technology |
|---|---|---|
| Sector | Pharma intermediates: anti-depressants, anti-virals | Performance chemicals: HALS, guaiacol, BHA (green chemistry) |
| Market Cap | approximately Rs 6,000 Cr (approx) | Rs 8,205 Cr |
| P/E Ratio | approximately 40x (approx) | 35.22x |
| ROE | approximately 12% (approx) | 14.50% |
| Debt to Equity | Low | Zero |
| Exports | Global pharma (US, EU, Japan) | Global specialty chemicals (EU, Japan, US) |
| Dividend | Minimal | 0.52% yield |
Conclusion
The Ami Organics vs Clean Science and Technology comparison above covers the key data points on reach, products, results and valuation. Ami Organics vs Clean Science and Technology covers two Indian specialty chemical companies serving global pharma and industrial clients. Ami Organics has a pharma intermediate franchise with specific molecule expertise. Clean Science has a proprietary green chemistry performance chemical portfolio. Ami Organics vs Clean Science investors should review end-market pharma and polymer demand, customer concentration and green chemistry cost advantages. Ami Organics vs Clean Science are both small specialty chemical companies – consult a SEBI-registered advisor for personalised guidance.
Download the Univest iOS App or Univest Android App to track Ami Organics and Clean Science and Technology live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does Ami Organics make?
Ans. Ami Organics makes pharmaceutical intermediates – specialty chemicals used in the synthesis of active pharmaceutical ingredients (APIs). It is known for intermediates for sertraline (antidepressant), favipiravir (antiviral) and apixaban (anticoagulant) drug classes.
What does Clean Science and Technology make?
Ans. Clean Science makes performance chemicals including HALS (Hindered Amine Light Stabilisers for polymer UV protection), guaiacol, anisole, BHA, methoxy toluene and Dimethyl Carbonate, using proprietary green chemistry that avoids waste-generating oxidation steps.
What is green chemistry?
Ans. Green chemistry designs chemical processes to reduce or eliminate hazardous substances. Clean Science’s processes are known for using hydrogen peroxide or air as oxidants instead of chlorine-based chemistry, producing fewer toxic byproducts and lower manufacturing waste.
Does Clean Science pay dividends?
Ans. Yes. Clean Science pays a dividend yield of approximately 0.52 percent.
Are Ami Organics and Clean Science in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in Nifty 500 and smaller indices.
What is a pharma intermediate?
Ans. A pharma intermediate is a chemical compound that is produced in the middle of the synthesis of an API (Active Pharmaceutical Ingredient). Ami Organics sells these intermediates to global pharma companies that complete the final API synthesis.
Which is larger, Ami Organics or Clean Science?
Ans. Clean Science (Rs 8,205 Cr) is slightly larger than Ami Organics (approximately Rs 6,000 Cr).